164 related articles for article (PubMed ID: 34829869)
1. Agent Clustering Strategy Based on Metabolic Flux Distribution and Transcriptome Expression for Novel Drug Development.
Ruan Y; Chen XH; Jiang F; Liu YG; Liang XL; Lv BM; Zhang HY; Zhang QY
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829869
[TBL] [Abstract][Full Text] [Related]
2. Revisiting Connectivity Map from a gene co-expression network analysis.
Liu W; Tu W; Li L; Liu Y; Wang S; Li L; Tao H; He H
Exp Ther Med; 2018 Aug; 16(2):493-500. PubMed ID: 30112021
[TBL] [Abstract][Full Text] [Related]
3. Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map.
Yoo M; Shin J; Kim H; Kim J; Kang J; Tan AC
Comput Methods Programs Biomed; 2019 Jun; 174():33-40. PubMed ID: 29650251
[TBL] [Abstract][Full Text] [Related]
4. Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning.
He J; Yan H; Cai H; Li X; Guan Q; Zheng W; Chen R; Liu H; Song K; Guo Z; Wang X
J Transl Med; 2017 Sep; 15(1):198. PubMed ID: 28962576
[TBL] [Abstract][Full Text] [Related]
5. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing for Japanese Encephalitis Virus Infection by Systems Biology Methods.
Lv BM; Tong XY; Quan Y; Liu MY; Zhang QY; Song YF; Zhang HY
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567313
[TBL] [Abstract][Full Text] [Related]
7. Physiologically Shrinking the Solution Space of a Saccharomyces cerevisiae Genome-Scale Model Suggests the Role of the Metabolic Network in Shaping Gene Expression Noise.
Chi B; Tao S; Liu Y
PLoS One; 2015; 10(10):e0139590. PubMed ID: 26448560
[TBL] [Abstract][Full Text] [Related]
8. Use of GC-MS based metabolic fingerprinting for fast exploration of fungicide modes of action.
Hu Z; Dai T; Li L; Liu P; Liu X
BMC Microbiol; 2019 Jun; 19(1):141. PubMed ID: 31234789
[TBL] [Abstract][Full Text] [Related]
9. Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis.
Ravindranath AC; Perualila-Tan N; Kasim A; Drakakis G; Liggi S; Brewerton SC; Mason D; Bodkin MJ; Evans DA; Bhagwat A; Talloen W; Göhlmann HW; Shkedy Z; Bender A;
Mol Biosyst; 2015 Jan; 11(1):86-96. PubMed ID: 25254964
[TBL] [Abstract][Full Text] [Related]
10. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
[TBL] [Abstract][Full Text] [Related]
11. Influence of batch effect correction methods on drug induced differential gene expression profiles.
Zhou W; Koudijs KKM; Böhringer S
BMC Bioinformatics; 2019 Aug; 20(1):437. PubMed ID: 31438848
[TBL] [Abstract][Full Text] [Related]
12. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
13. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
14. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
[TBL] [Abstract][Full Text] [Related]
15. Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform.
Gao S; Han L; Luo D; Liu G; Xiao Z; Shan G; Zhang Y; Zhou W
BMC Bioinformatics; 2021 Jan; 22(1):17. PubMed ID: 33413089
[TBL] [Abstract][Full Text] [Related]
16. Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning.
Han L; Shan G; Chu B; Wang H; Wang Z; Gao S; Zhou W
Cogn Neurodyn; 2023 Jun; 17(3):803-811. PubMed ID: 34777628
[TBL] [Abstract][Full Text] [Related]
17. Gene-Set Local Hierarchical Clustering (GSLHC)--A Gene Set-Based Approach for Characterizing Bioactive Compounds in Terms of Biological Functional Groups.
Chung FH; Jin ZH; Hsu TT; Hsu CL; Liu HC; Lee HC
PLoS One; 2015; 10(10):e0139889. PubMed ID: 26473729
[TBL] [Abstract][Full Text] [Related]
18. A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data.
Wang F; Lei X; Wu FX
Curr Med Chem; 2020; 27(32):5340-5350. PubMed ID: 30381060
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of connectivity map shows limited reproducibility in drug repositioning.
Lim N; Pavlidis P
Sci Rep; 2021 Sep; 11(1):17624. PubMed ID: 34475469
[TBL] [Abstract][Full Text] [Related]
20. Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection.
Wang S; Liu Y; Guo J; Wang P; Zhang L; Xiao G; Wang W
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
